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Chitosan (CS) is a plentiful natural polysaccharide that is
non-toxic, biocompatible and biodegradable.1—3) It has been
investigated as a vehicle for the sustained release of drugs,4)
and as an absorption enhancer of drugs by mucoadhesion to
the gastric cavity and the nasal cavity.5—7) The preparation of
CS microspheres has also been studied.8,9) We found that CS
gel spheres formed at around pH 9 in amino acid solution,
despite usually forming a gel in solutions with a pH .12.10)
Drug release from the gel beads prepared at pH 9 was inhib-
ited compared with that from the pH .12 gel beads, because
of reduced CS degradation to low molecular weight. Drug re-
lease was further slowed by forming a complex between
chondroitin sulfate (Cho) and CS.11) Furthermore, the CS gel
beads could be implanted into subcutaneous air pouches
(AP) prepared on the dorsal surface of mice, with the in vivo
release of the drug reflected in the in vitro release.12)
We investigated the preparation of a suitable vehicle, as an
example, for intra-articular injection in rheumatoid arthritis
to allow sustained drug delivery. Intra-articular injection of
steroids is commonly used in the treatment of this condition.
Under such conditions, it is difficult to achieve a sustained
intra-articular drug level because of the solubility of the
drug. It is therefore necessary to use a vehicle that controls
drug release. The materials that are implanted in the body
must be non-toxic, biocompatible and biodegradable if they
are to avoid the host’s defense system during their long-term
contact with living structures. Lu et al.13) reported that CS
could act on the epiphyseal cartilage and augment wound
healing of articular cartilage. Cho, which is a mucopolysac-
charide similar to CS, is biocompatible and biodegradable. It
is also a component of cartilage and is used in the clinical
treatment of wound healing of articular cartilage. Therefore,
CS gel beads modified by Cho (CS-Cho gel beads) might be
useful for healing wounds in articular cartilage after fulfilling
a role as a vehicle for drug delivery. In this study, we investi-
gated in vivo biodegradation and drug release profiles of CS-
Cho gel beads by implanting the gel beads into subcutaneous
AP prepared on the dorsal surface of mice.
MATERIALS AND METHODS
Materials CS with various degrees of deacetylation
(70% (7B), 80% (8B), 90% (9B), 100% (10B)) was pur-
chased from Katokichi Co., Ltd., Japan. The molecular
weights of the CS were 2210000 (CS7B), 2140000 (CS8B),
900000 (CS9B) and 950000 (CS10B).1) Cho (chondroitin
sulfate C sodium salt) was purchased from Wako Pure
Chemical Industries, Japan. Prednisolone (PS) was pur-
chased from Nacalai Tesque Inc., Japan. The other reagents
were obtained from either Wako Pure Chemical Industries or
Nacalai Tesque Inc.
Preparation of CS Gel Beads CS gel beads were pre-
pared as follows. CS (1—2% w/w) was dissolved in 0.1 M ac-
etate buffer (pH 4.5) and 1% PS was then added to the CS
solution. One gram of this suspension, theoretically contain-
ing 10 mg of PS, was dropped slowly into 20 ml of 10%
glycine solution (pH 9.0) using a pipette and left at room
temperature for 25 min. Hydrogel beads formed sponta-
neously and were dried at 37 °C for 24 h in a dish before
holding them under vacuum in a desiccator in the presence of
P2O5.
Preparation of CS-Cho Gel Beads CS hydrogel beads
were soaked in 20 ml of 1% Cho aqueous solution (1—48 h).
The gel beads were removed from the solution and dried at
37 °C for 24 h in a dish, before holding them under vacuum
in a desiccator in the presence of P2O5.
Preparation of Gel Beads for Implantation Before im-
plantation the dried beads were washed with distilled/dem-
ineralized water and returned to the hydrogel to remove
glycine because of the effect of glycine on living tissue.
Dissolution Test The release of PS from the various gel
beads into 0.1 M phosphate buffer (pH 7.2) was determined.
Dried gel beads, corresponding to 1 g of hydrogel, were
added to 500 ml of dissolution medium in a JP XIII dissolu-
tion test apparatus (paddle method, 100 rpm, 37 °C). A 4-ml
aliquot of the solution was removed periodically for analysis
and replaced with 4 ml of the dissolution medium (pre-
warmed to 37 °C) to maintain a constant volume. The ab-
sorbance of each sample was determined with a Hitachi
model 200-20 spectrophotometer at 246 nm. All the dissolu-
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Chitosan (CS) gel beads were prepared in 10% amino acid solution (pH 9) and modified by forming an elec-
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This effect makes these beads a promising biocompatible and biodegradable vehicle for sustained drug delivery.
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tion tests were performed in triplicate.
In Vivo Biodegradation and Drug Release of Gel Beads
The biodegradation of gel beads implanted into mice and the
in vivo release of PS were investigated as follows. Air (3 ml)
was injected subcutaneously into the dorsal surface of mice
(ddy, male, 5—6-weeks-old) to form air pouches. An oval
AP was formed after an additional 1 ml of air was injected at
days 1 and 4. A grain of beads was implanted into the AP
under anesthesia with ether 7 d after the first injection of air.
The beads were retrieved from the AP under anesthesia with
pentobarbital sodium and contents of the AP were collected
by washing with 1 ml of physiological saline three times. The
abdominal skin was then opened and blood was collected
from the vena cava caudalis. The PS concentrations in the
plasma and the amount of PS in the gel beads and AP were
determined.
Determination of Plasma PS Concentration Blood
samples were centrifuged at 3500 rpm for 5 min. The super-
natant (100 m l) was then added to 500 m l of 20% trichlo-
roacetic acid aqueous solution to remove protein, 200 m l 
of 4 mg/ml methyl p-hydroxybenzoate aqueous solution as
internal standard, and 200 m l of distilled/demineralized 
water. The mixture was centrifuged at 3500 rpm for 5 min
and the supernatant was then loaded into a sample extrac-
tion product (OASIS HLB, Waters). The extracted sample
was subjected to high-performance liquid chromatography
(HPLC). A 20-m l aliquot of the sample was loaded onto a
column (YMC-Pack Pro C18; 150 mm33.0 mm) and elut-
ed with 25% tetrahydrofuran (THF) aqueous solution as the
mobile phase at a flow rate of 0.3 ml/min (Shimadzu LC-
10AS). PS in the effluent from the column was detected at
246 nm with a UV spectrophotometer (Shimadzu SPD-
10AVVP).
Determination of PS in the Gel Beads CS gel beads
were dissolved in 2 ml of 0.1 M acetate buffer (pH 4.5). These
samples were added to 50 m l of 200 mg/ml internal standard
made up in 25% THF aqueous solution, and made up to 5 ml
with 25% THF aqueous solution. The mixture was cen-
trifuged at 3500 rpm for 5 min, and the supernatant was fil-
tered (Cosmonice Filter S, 0.5 mm, Millipore) and subjected
to HPLC as described above.
Determination of PS in the AP The contents of the AP
were added to 50 m l of 200 mg/ml internal standard made up
in 25% THF aqueous solution, and made up to 5 ml with
physiological saline. One milliliter of the mixture was added
to 1 ml of 50% MeOH and centrifuged at 3500 rpm for
5 min. The supernatant was filtered (Cosmonice Filter S,
0.5 mm, Millipore) and subjected to HPLC as described
above.
Evaluation of Biocompatibility Biocompatibility was
evaluated on the inflammatory response, characterized in
terms of the amount of protein in the AP, and compared with
injection of 30 mg carrageenin with 1 ml of physiological
saline which is known to induce inflammation.14) The protein
content of the AP was determined by the method of Lowry et
al.15) using 350 m l of the mixture prepared for determination
of PS in the AP as described above.
RESULTS AND DISCUSSION
Characteristics of CS Gel Beads The preparation of the
CS gel beads was affected by the properties of the CS. The
optimum concentrations for the formation of gel spheres
were 1% for both CS7B and CS8B, and 1.5 and 2% for
CS9B. Lower concentrations of CS did not form gel spheres
and higher concentrations were difficult to drop by pipette
because of their high viscosity. CS10B did not form gel
spheres even at higher concentrations. The dried CS gel
beads retained more than 95% of the theoretical total amount
of PS, a glycine content of about 51% of their dry weight and
had a diameter of about 3.5 mm. Glycine was detected by a
modification of the method of Watanabe and Imai.16)
Characteristics of CS-Cho Gel Beads The amount of
PS retained in the CS-Cho gel beads decreased with rise in
soaking time in 1% Cho solution; 76, 70, 39 and 27% of the
theoretical total amount of PS was retained in the dried 1%
CS7B-Cho gel beads after soaking for 1, 6, 24 and 48 h, re-
spectively. The dried 1% CS8B-Cho, 1.5% CS9B-Cho and
2% CS9B-Cho gel beads, soaked in 1% Cho solution for 6 h,
retained about 62, 82 and 91% of the theoretical total amount
of PS, respectively.
Characteristics of Beads for Implantation The hydro-
gel beads for implantation retained 370—700 mg of PS per
grain, had a diameter of 4.3—5.4 mm and a glycine content
of ,1.56 mg (the limit of detection).
In Vitro Release of PS from CS-Cho Gel Beads The
release of PS from 1% CS7B gel beads was inhibited by
treatment with Cho (Fig. 1). The sustained release of PS
from CS-Cho gel beads resulted from the formation of an
electrostatic complex between the carboxyl group of Cho and
the amino group of CS.11) However, the profile of PS release
changed very little with soaking time (1—48 h), indicating
that the complex between CS and Cho forms on the surface
of the CS gel beads. Beads soaked for 6 h in 1% Cho solution
were used in subsequent studies, because the amount of PS
retained decreased as the soaking time in 1% Cho solution
increased. The amount of PS retained in CS-Cho gel beads
also differed with CS species. However, the release pattern
was not changed by changing the amount of PS retained in
the beads. Figure 2 shows the percentage of PS released after
6 h from CS-Cho gel beads that had been soaked in 1% Cho
solution for 6 h. The effect of modification of the CS gel by
Cho on the release of PS from the beads was observed re-
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Fig. 1. Effect of Cho Treatment of 1% CS7B Gel Beads on the Release of
PS
Soaking time in Cho solution: 6 h. Data represent the mean6S.D. (n53).
gardless of CS species. The release of PS from 2% CS9B gel
beads was inhibited compared with that from the others. This
is assumed to be because the matrix of 2% CS9B gel beads is
denser than that of the others, because the diameter of 2%
CS9B gel beads was the same as others despite higher vis-
cosity.
Evaluation of Biocompatibility The amount of protein
in the AP 3 d after implantation of CS-Cho gel beads without
PS was determined to evaluate the inflammatory response
(Fig. 3). No increase in protein was observed compared to
mice injected with 30 mg carrageenin in 1 ml of physiologi-
cal saline, which is known to induce inflammation. This re-
sult was similar to CS gel beads without Cho treatment,12) in-
dicating the biocompatibility of CS-Cho gel beads.
In Vivo Biodegradation of Gel Beads Gel beads with
various degrees of deacetylation, 1% CS7B, 1% CS8B, 1.5%
and 2% CS9B, with and without Cho, were implanted in the
AP of five mice per treatment. The number of beads that re-
mained and maintained their shape over time is shown in
Table 1. Biodegradation of the CS gel beads was accelerated
as their degree of deacetylation decreased. Both CS7B and
CS8B beads degraded in less than 3 d after implantation.
However, some of the 1.5% and 2% CS9B gel beads re-
mained even after 14 d. Mucopolysaccharides are hydrolyz-
ed by enzymes such as lysozymes, it was reported that
biodegradation of CS was increased as their degree of
deacetylation decreased.1,3,10) In a previous study CS gel
beads were degraded in 0.1 M phosphate buffer (pH 7.2) con-
taining lysozyme, although no degradation of the beads was
observed without lysozyme.11) Degradation of the gel beads
in AP is therefore not erosion but biodegradation. On the
other hand, biodegradation of all the CS-Cho gel beads was
inhibited compared with beads without Cho treatment. These
results indicated that modification of the CS gel matrix by
Cho could control biodegradation of these beads. This as-
sumes that the matrix is a dense complex between CS and
Cho and that erosion by the enzymes is inhibited. However,
1% CS7B-Cho and 1% CS8B-Cho gel were degraded before
5 d, and 1.5 and 2% CS9B-Cho gel beads after 28 d became
softer and smaller than before implantation. Therefore, even
CS gel beads modified by Cho are susceptible to biodegrada-
tion.
In Vivo Release of PS from Gel Beads The in vivo re-
lease of PS from gel beads was evaluated by measuring the
percentage of residual PS in the beads and AP compared
with the amount administered. In a previous study,12) 1% PS
suspended in physiological saline was injected into the AP.
PS immediately started disappearing from the site: 19.7, 2.4
and 0.2% of administered PS remained in the AP after 1, 5
and 24 h, respectively. The plasma level changed gradually
according to the amount of PS in the AP as it passed rapidly
into the blood-stream. A similar result was obtained in the
case of PS suspended in 1% CS7B acetate buffer solution
(pH 4.5). These results showed that when PS powder was
dissolved in the exudate in the AP, it did not remain there for
long even with viscous CS.
To reduce side-effects and prolong the duration of the ac-
tivity of a drug it is necessary to use a vehicle to deliver the
drug. As shown in Fig. 4, PS remained in all the gel beads
1 d after implantation. In the case of 2% CS9B gel beads
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Fig. 2. Effect of CS Species on the Release of PS after Dissolution Test
for 6 h
Data represent the mean6S.D. (n53). * p,0.05, ** p,0.01: significantly different
from CS gel without Cho. (Student’s t-test).
Fig. 3. Amount of Protein in the AP 3 d after Implantation of CS-Cho Gel
Beads
Control: only incision (no implantation). Data represent the mean6S.D. (n53—8).
Table 1. Effect of Gel Species on the Number of Gel Beads Remaining after Implantation
After 1% CS7B 1% CS8B 1.5% CS9 2% CS9B
implantation (d)
CS CS-Cho CS CS-Cho CS CS-Cho CS CS-Cho
1 3 5 5 5 5 5 5 5
3 0 1 0 4 5 5 5 5
5 — 0 — 0 4 5 5 5
7 — — — — 4 5 4 4
14 — — — — 2 5 1 5
28 — — — — 0 5 0 5
A grain of beads was implanted into the AP of a mouse. Data represent the number of gel beads that remained and maintained their shape. (n55).
after 3 d, about 30% of the PS remained, about 0.05% re-
mained in the AP and PS was not determined in plasma. This
result indicates that PS was released into the AP more gradu-
ally from the CS gel beads. Furthermore, the percentage of
residual PS in the beads was increased by modification of the
CS gel matrix by Cho. In the case of 2% CS9B-Cho, about
50% of the PS remained in the beads after 3 d. The percent-
age of residual PS in the beads increased about 20% com-
pared with beads without Cho treatment. However, all of the
PS had been released from the beads before 3 d (1% CS7B
and CS8B) or 5 d (1% CS7B-Cho and CS8B-Cho) as degra-
dation accelerated. On the other hand, PS was detected in the
gel beads after 5 d (some 1.5% CS9B) and 7 d (some 2%
CS9B, 1.5% CS9B-Cho and 2% CS9B-Cho) as there was no
degradation. Changing the type of CS or modifying the CS
would control the in vivo release of PS from the beads.
These results show that PS release in AP of mice is gov-
erned by both diffusion and degradation of the gel matrix.
The control of biodegradation and drug release from a vehi-
cle will make possible the supply of the minimum require-
ment of a dose by local application, and may result in a pro-
longation of drug activity and a reduction in side effects.
Control of biodegradation and drug release of CS gel beads
in vivo was achieved by forming an electrostatic complex be-
tween Cho and CS. Thus, these beads appear promising as a
biodegradable vehicle for sustained drug delivery.
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Fig. 4. Effect of Gel Species on the Percentage of Residual PS in the Gel Beads
Residual PS in the gel beads (%): residual/administered. Data represent the mean6S.D. (n55). * p,0.05: significantly different from CS gel without Cho. (Student’s t-test).
